Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up y

被引:775
作者
Pavel, M. [1 ]
Oberg, K. [2 ]
Falconi, M. [3 ]
Krenning, E. P. [4 ]
Sundin, A. [5 ]
Perren, A. [6 ]
Berruti, A. [7 ]
机构
[1] Univ Hosp Erlangen, Dept Med 1, Erlangen, Germany
[2] Uppsala Univ, Dept Endocrine Oncol, Uppsala, Sweden
[3] IRCCS San Raffaele Sci Inst, Dept Surg, Milan, Italy
[4] Cyclotron Rotterdam BV, Erasmus Med Ctr, Rotterdam, Netherlands
[5] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden
[6] Univ Bern, Inst Pathol, Bern, Switzerland
[7] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Med Oncol Unit, ASST Spedali Civili, Brescia, Italy
关键词
RECEPTOR RADIONUCLIDE THERAPY; ENETS CONSENSUS GUIDELINES; LIVER METASTASES; OCTREOTIDE-LAR; PHASE-III; GA-68-DOTA-TYR(3)-OCTREOTIDE PET; GASTROINTESTINAL-TRACT; TYR(3) OCTREOTATE; ENDOCRINE TUMORS; DOUBLE-BLIND;
D O I
10.1016/j.annonc.2020.03.304
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:844 / 860
页数:17
相关论文
共 106 条
[81]   Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group [J].
Rinke, Anja ;
Mueller, Hans-Helge ;
Schade-Brittinger, Carmen ;
Klose, Klaus-Jochen ;
Barth, Peter ;
Wied, Matthias ;
Mayer, Christina ;
Aminossadati, Behnaz ;
Pape, Ulrich-Frank ;
Blaeker, Michael ;
Harder, Jan ;
Arnold, Christian ;
Gress, Thomas ;
Arnold, Rudolf .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (28) :4656-4663
[82]   Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver Metastases [J].
Ronot, Maxime ;
Clift, Ashley K. ;
Baum, Richard P. ;
Singh, Aviral ;
Kulkarni, Harshad R. ;
Frilling, Andrea ;
Vilgrain, Valerie .
NEUROENDOCRINOLOGY, 2018, 106 (01) :74-88
[83]   Whole-genome landscape of pancreatic neuroendocrine tumours [J].
Scarpa, Aldo ;
Chang, David K. ;
Nones, Katia ;
Corbo, Vincenzo ;
Patch, Ann-Marie ;
Bailey, Peter ;
Lawlor, Rita T. ;
Johns, Amber L. ;
Miller, David K. ;
Mafficini, Andrea ;
Rusev, Borislav ;
Scardoni, Maria ;
Antonello, Davide ;
Barbi, Stefano ;
Sikora, Katarzyna O. ;
Cingarlini, Sara ;
Vicentini, Caterina ;
McKay, Skye ;
Quinn, Michael C. J. ;
Bruxner, Timothy J. C. ;
Christ, Angelika N. ;
Harliwong, Ivon ;
Idrisoglu, Senel ;
McLean, Suzanne ;
Nourse, Craig ;
Nourbakhsh, Ehsan ;
Wilson, Peter J. ;
Anderson, Matthew J. ;
Fink, J. Lynn ;
Newell, Felicity ;
Waddell, Nick ;
Holmes, Oliver ;
Kazakoff, Stephen H. ;
Leonard, Conrad ;
Wood, Scott ;
Xu, Qinying ;
Nagaraj, Shivashankar Hiriyur ;
Amato, Eliana ;
Dalai, Irene ;
Bersanif, Samantha ;
Cataldo, Ivana ;
Tos, Angelo P. Dei ;
Capelli, Paola ;
Davi, Maria Vittoria ;
Landoni, Luca ;
Malpaga, Anna ;
Miotto, Marco ;
Whitehall, Vicki L. J. ;
Leggett, Barbara A. ;
Harris, Janelle L. .
NATURE, 2017, 543 (7643) :65-+
[84]   Comparison of abdominal MRI with diffusion-weighted imaging to 68Ga-DOTATATE PET/CT in detection of neuroendocrine tumors of the pancreas [J].
Schmid-Tannwald, Christine ;
Schmid-Tannwald, Christoph M. ;
Morelli, John N. ;
Neumann, Ralph ;
Haug, Alexander R. ;
Jansen, Nathalie ;
Nikolaou, Konstantin ;
Schramm, Nicolai ;
Reiser, Maximilian F. ;
Rist, Carsten .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2013, 40 (06) :897-907
[85]   Peptide receptor radionuclide therapy in the management of gastrointestinal neuroendocrine tumors: efficacy profile, safety, and quality of life [J].
Severi, Stefano ;
Grassi, Ilaria ;
Nicolini, Silvia ;
Sansovini, Maddalena ;
Bongiovanni, Alberto ;
Paganelli, Giovanni .
ONCOTARGETS AND THERAPY, 2017, 10 :551-557
[86]   Can Complementary 68Ga-DOTATATE and 18F-FDG PET/CT Establish the Missing Link Between Histopathology and Therapeutic Approach in Gastroenteropancreatic Neuroendocrine Tumors? [J].
Simsek, Duygu Has ;
Kuyumcu, Serkan ;
Turkmen, Cuneyt ;
Sanli, Yasemin ;
Aykan, Faruk ;
Unal, Seher ;
Adalet, Isik .
JOURNAL OF NUCLEAR MEDICINE, 2014, 55 (11) :1811-1817
[87]   Everolimus in Neuroendocrine Tumors of the Gastrointestinal Tract and Unknown Primary [J].
Singh, Simron ;
Carnaghi, Carlo ;
Buzzoni, Roberto ;
Pommier, Rodney F. ;
Raderer, Markus ;
Tomasek, Jiri ;
Lahner, Harald ;
Valle, Juan W. ;
Voi, Maurizio ;
Bubuteishvili-Pacaud, Lida ;
Lincy, Jeremie ;
Wolin, Edward ;
Okita, Natsuko ;
Libutti, Steven K. ;
Oh, Do-Youn ;
Kulke, Matthew ;
Strosberg, Jonathan ;
Yao, James C. ;
Pavel, Marianne E. ;
Fazio, Nicola .
NEUROENDOCRINOLOGY, 2018, 106 (03) :211-220
[88]   Gastroenteropancreatic High-Grade Neuroendocrine Carcinoma [J].
Sorbye, Halfdan ;
Strosberg, Jonathan ;
Baudin, Eric ;
Klimstra, David S. ;
Yao, James C. .
CANCER, 2014, 120 (18) :2814-2823
[89]   Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors [J].
Strosberg, J. ;
El-Haddad, G. ;
Wolin, E. ;
Hendifar, A. ;
Yao, J. ;
Chasen, B. ;
Mittra, E. ;
Kunz, P. L. ;
Kulke, M. H. ;
Jacene, H. ;
Bushnell, D. ;
O'Dorisio, T. M. ;
Baum, R. P. ;
Kulkarni, H. R. ;
Caplin, M. ;
Lebtahi, R. ;
Hobday, T. ;
Delpassand, E. ;
Van Cutsem, E. ;
Benson, A. ;
Srirajaskanthan, R. ;
Pavel, M. ;
Mora, J. ;
Berlin, J. ;
Grande, E. ;
Reed, N. ;
Seregni, E. ;
Oberg, K. ;
Sierra, M. Lopera ;
Santoro, P. ;
Thevenet, T. ;
Erion, J. L. ;
Ruszniewski, P. ;
Kwekkeboom, D. ;
Krenning, E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (02) :125-135
[90]   Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial [J].
Strosberg, Jonathan ;
Wolin, Edward ;
Chasen, Beth ;
Kulke, Matthew ;
Bushnell, David ;
Caplin, Martyn ;
Baum, Richard P. ;
Kunz, Pamela ;
Hobday, Timothy ;
Hendifar, Andrew ;
Oberg, Kjell ;
Sierra, Maribel Lopera ;
Thevenet, Thomas ;
Margalet, Ines ;
Ruszniewski, Philippe ;
Krenning, Eric .
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (25) :2578-+